ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

LQDA Liquidia Corporation

12.79
-0.19 (-1.46%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Liquidia Corporation LQDA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.19 -1.46% 12.79 09:00:00
始値 安値 高値 終値 前日終値
13.15 12.66 13.23 12.79 12.98
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0222:00GLOBELiquidia Corporation to Present at 23rd Annual Needham..
2024/4/0119:00GLOBEUpdate on Favorable Legal and Regulatory Outcomes Clearing..
2024/3/1319:00GLOBELiquidia Corporation Reports Full Year 2023 Financial..
2024/3/0620:30GLOBELiquidia Corporation to Report Full Year 2023 Financial..
2024/3/0509:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3020:30GLOBELiquidia Corporation Announces Poster Presentation at the..
2024/1/2521:01EDGAR2Form 8-K - Current report
2024/1/2520:00GLOBELiquidia Corporation Provides Update on New Drug Application..
2024/1/2321:30EDGAR2Form 8-K - Current report
2024/1/1921:01EDGAR2Form 8-K - Current report
2024/1/1920:30GLOBELiquidia Corporation Announces Updates to Operations..
2024/1/1707:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1707:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1707:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1621:42EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0906:15EDGAR2Form 8-K - Current report
2024/1/0822:22GLOBELiquidia Corporation Files Response to United Therapeutics..
2024/1/0520:45GLOBELiquidia Provides Update on Clinical Pipeline Targeting PAH..
2024/1/0511:37EDGAR2Form 8-K - Current report
2024/1/0423:10GLOBELiquidia Corporation Announces $100 Million in New..
2024/1/0414:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/0220:45GLOBELiquidia Corporation to Present at 42nd Annual J.P. Morgan..
2023/12/2906:30EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/12/2306:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/2107:16EDGAR2Form 8-K - Current report
2023/12/2106:56GLOBEU.S. Federal Circuit Affirms Earlier PTAB Decision to..
2023/12/1910:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1506:02EDGAR2Form 8-K - Current report
2023/12/1306:41EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2023/12/1222:44EDGAR2Form 8-K - Current report
2023/12/1221:13GLOBELiquidia Announces Pricing of Public Offering of Common..
2023/12/1221:04EDGAR2Form 8-K - Current report
2023/12/0611:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0611:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0122:30EDGAR2Form 8-K - Current report
2023/11/0721:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0720:36EDGAR2Form 8-K - Current report
2023/11/0720:30GLOBELiquidia Corporation Reports Third Quarter 2023 Financial..
2023/10/3119:30GLOBELiquidia Corporation to Report Third Quarter 2023 Financial..
2023/10/0220:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
2023/9/2606:00EDGAR2Form 8-K - Current report
2023/9/2605:09GLOBEFDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
2023/9/0705:37EDGAR2Form 8-K - Current report
2023/9/0705:30GLOBEUnited Therapeutics Corporation Files Lawsuit Alleging..
2023/9/0609:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0609:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2119:00EDGAR2Form 8-K - Current report
2023/8/1019:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1019:00GLOBELiquidia Corporation Reports Second Quarter 2023 Financial..
2023/8/1019:00EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock